Clinical Characteristics of Early-Onset and Late-Onset Multiple Sclerosis in Patients from Lithuania

被引:0
作者
Slajute, Emilija [1 ]
Vickacka, Naglis [1 ]
Klegeris, Tautvydas [2 ]
Uloziene, Ingrida [2 ]
Balnyte, Renata [3 ]
机构
[1] Lithuanian Univ Hlth Sci, Fac Med, LT-44307 Kaunas, Lithuania
[2] Lithuanian Univ Hlth Sci, Fac Med, Dept Otorhinolaryngol, LT-44307 Kaunas, Lithuania
[3] Lithuanian Univ Hlth Sci, Fac Med, Dept Neurol, LT-44307 Kaunas, Lithuania
来源
MEDICINA-LITHUANIA | 2025年 / 61卷 / 01期
关键词
multiple sclerosis; early-onset multiple sclerosis; late-onset multiple sclerosis; relapse; disability; RISK;
D O I
10.3390/medicina61010107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Early-onset MS (EOMS) and late-onset MS (LOMS) differ in terms of symptom presentation, disease progression, and disability outcomes. This study aims to evaluate the clinical characteristics of patients with EOMS and LOMS in Lithuania. Materials and Methods: A retrospective analysis of patients' medical records was conducted at the Lithuanian University of Health Sciences, Kaunas Clinics Department of Neurology. This study included 97 patients with multiple sclerosis, of which 34 were diagnosed with EOMS and 63 with LOMS. Results: The female/male ratio did not differ significantly in the EOMS group (1.26:1), while in the LOMS group, the female-to-male ratio was 2:1. All EOMS patients were diagnosed with relapsing-remitting multiple sclerosis (RRMS), while in the LOMS group, RRMS was observed in 55.6%, secondary progressive multiple sclerosis (SPMS) was observed in 27%, and primary progressive multiple sclerosis (PPMS) was observed in 17.4% of patients (p < 0.001). The most common initial symptoms in the EOMS group were brainstem dysfunction (50%), and sensory (38.2%) and visual (26.5%) disorders, whereas LOMS patients predominantly experienced brainstem dysfunction (50.8%) and motor impairments (47.6%). The EOMS group experienced more clinical relapses in the first year after diagnosis, along with more frequent radiological signs of disease activity compared to LOMS (p < 0.001). Both groups demonstrated a significant increase in Expanded Disability Status Scale (EDSS) score at the last follow-up visit compared to the baseline, while the LOMS group had higher EDSS scores both at the baseline and at the last follow-up compared to the EOMS group (p < 0.001). Only LOMS patients had an increase in Multiple Sclerosis Severity Score (MSSS) at the last follow-up compared to the baseline (p = 0.028), and MSSS was higher than in EOMS patients both at the baseline (p = 0.004) and the last follow-up (p < 0.001). Conclusions: There was no significant gender difference in the EOMS group, whereas in the LOMS group, females were predominant. Both groups had RRMS as the most common disease course. At the onset of MS, brainstem dysfunction was the most common symptom in both patient groups. EOMS patients had a more active disease course, in contrast to LOMS patients, who exhibited higher levels of disability, suggesting a progressive disease.
引用
收藏
页数:11
相关论文
共 38 条
  • [1] Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice
    Ahn, Jeeyoon Jennifer
    O'Mahony, Julia
    Moshkova, Marina
    Hanwell, Heather E.
    Singh, Hargurinder
    Zhang, Monan Angela
    Marrie, Ruth Ann
    Bar-Or, Amit
    Sadovnick, Dessa A.
    Dunn, Shannon E.
    Banwell, Brenda L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 735 - 748
  • [2] Updates and advances in multiple sclerosis neurotherapeutics
    Amin, Moein
    Hersh, Carrie M.
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2023, 13 (01) : 47 - 70
  • [3] Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis
    Baroncini, Damiano
    Simone, Marta
    Iaffaldano, Pietro
    Brescia Morra, Vincenzo
    Lanzillo, Roberta
    Filippi, Massimo
    Romeo, Marzia
    Patti, Francesco
    Chisari, Clara Grazia
    Cocco, Eleonora
    Fenu, Giuseppe
    Salemi, Giuseppe
    Ragonese, Paolo
    Inglese, Matilde
    Cellerino, Maria
    Margari, Lucia
    Comi, Giancarlo
    Zaffaroni, Mauro
    Ghezzi, Angelo
    [J]. JAMA NEUROLOGY, 2021, 78 (06) : 726 - 735
  • [4] Impact of natural menopause on multiple sclerosis: a multicentre study
    Baroncini, Damiano
    Annovazzi, Pietro Osvaldo
    De Rossi, Nicola
    Mallucci, Giulia
    Clerici, Valentina Torri
    Tonietti, Simone
    Mantero, Vittorio
    Ferro, Maria Teresa
    Messina, Maria Jose
    Barcella, Valeria
    La Mantia, Loredana
    Ronzoni, Marco
    Barrila, Caterina
    Clerici, Raffaella
    Susani, Emanuela Laura
    Fusco, Maria Letizia
    Chiveri, Luca
    Abate, Lucia
    Ferraro, Ottavia
    Capra, Ruggero
    Colombo, Elena
    Confalonieri, Paolo
    Zaffaroni, Mauro
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (11) : 1201 - 1206
  • [5] Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years
    Benson, L. A.
    Healy, B. C.
    Gorman, M. P.
    Baruch, N. F.
    Gholipour, T.
    Musallam, A.
    Chitnis, T.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (02) : 186 - 193
  • [6] Hormones and MS: Risk factors, biomarkers, and therapeutic targets
    Bove, Riley
    Gilmore, Wendy
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (01) : 17 - 21
  • [7] The Clinical and Epidemiological Profile of Paediatric-Onset Multiple Sclerosis in Poland
    Brola, Waldemar
    Steinborn, Barbara
    Zak, Marek
    Mazurkiewicz-Beldzinska, Maria
    Jozwiak, Sergiusz
    Sobolewski, Piotr
    Wilski, Maciej
    Bilska, Malgorzata
    Siedlarska, Magdalena
    Puzio-Bochen, Iwona
    Wencel-Warot, Agnieszka
    Lemka, Malgorzata
    Kroczka, Slawomir
    Czyzyk, Elzbieta
    Bochenska, Malgorzata
    Emich-Widera, Ewa
    Pietruszewski, Jerzy
    Bockowski, Leszek
    Kapica-Topczewska, Katarzyna
    Czarnowska, Agata
    Kulakowska, Alina
    Ujma-Czapska, Barbara
    Gruna-Ozarowska, Agata
    Przyslo, Lukasz
    Polatynska, Katarzyna
    Dudzinska, Magdalena
    Mitosek-Szewczyk, Krystyna
    Melnyk, Aleksandra
    Adamczyk-Sowa, Monika
    Kotulska, Katarzyna
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [8] Paediatric multiple sclerosis - current diagnosis and treatment
    Brola, Waldemar
    Steinborn, Barbara
    [J]. NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (06) : 508 - 517
  • [9] Charlson Robert, 2016, Int J MS Care, V18, P265
  • [10] Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
    Correale, Jorge
    Ysrraelit, Maria Celica
    [J]. ASN NEURO, 2022, 14